心绞痛且冠状动脉无阻塞患者的血管运动功能性别差异
该研究纳入1379例稳定型心绞痛且冠状动脉无阻塞的患者,行乙酰胆碱激发试验评估血管痉挛或冠状动脉微血管功能障碍。结果显示女性血管运动功能障碍患病率显著高于男性(70% vs 43%),且女性在较低乙酰胆碱剂量下即出现阳性反应。
要点
- 女性心绞痛且冠脉无阻塞者血管运动功能障碍患病率显著高于男性。
- 女性冠状动脉微血管功能障碍的OR为4.2,心外膜血管痉挛OR为2.3。
- 女性对乙酰胆碱更敏感,较低剂量即可诱发血管运动功能障碍。
核心结论
- 在欧洲人群中,心绞痛且冠状动脉无阻塞的患者血管运动功能障碍常见,女性患病率高于男性,尤其冠状动脉微血管功能障碍。
- 女性在较低乙酰胆碱剂量下即可出现阳性乙酰胆碱激发试验。
研究设计与样本
- 2007至2014年连续纳入1379例稳定型心绞痛、冠状动脉无阻塞且行乙酰胆碱激发试验的患者。
- 平均年龄62岁,男性占42%。
- 采用逻辑回归分析性别、危险因素、症状及无创检查结果对阳性试验的预测价值。
主要发现
- 813例(59%)患者乙酰胆碱激发试验异常,其中33%为冠状动脉微血管功能障碍,26%为心外膜血管痉挛。
- 女性异常试验比例高于男性(70% vs 43%;p < 0.001)。
- 多变量逻辑回归中,女性-男性冠状动脉微血管功能障碍的OR为4.2(95%CI:3.1至5.5;p < 0.001),心外膜血管痉挛的OR为2.3(95%CI:1.7至3.1;p < 0.001)。
- 劳力相关症状有助于预测异常试验,而危险因素和无创负荷试验未显示预测作用。
- 女性患者对乙酰胆碱更敏感,血管运动功能障碍在较低乙酰胆碱剂量下发生。
临床怎么用
- 对于心绞痛但冠状动脉无阻塞的患者,尤其女性,应考虑血管运动功能障碍的可能。
- 乙酰胆碱激发试验可用于诊断冠状动脉微血管功能障碍和心外膜血管痉挛。
- 女性患者行乙酰胆碱激发试验时需注意其可能在较低剂量下出现阳性反应。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Coronary vasomotor dysfunction is an important mechanism for angina in patients with unobstructed coronary arteries. OBJECTIVES: The purpose of this study was to determine sex differences in the prevalence and clinical presentation of vasomotor dysfunction in a European population and to examine sex differences in the dose of acetylcholine leading to a positive acetylcholine provocation test (ACH test). METHODS: Between 2007 and 2014, we included 1,379 consecutive patients with stable angina, unobstructed coronaries and ACH test performed for epicardial vasospasm or coronary microvascular dysfunction (CMD) due to microvascular spasm. The predictive value of sex, risk factors, symptoms, and noninvasive test results was analyzed by means of logistic regression. RESULTS: The mean patient age was 62 years, and 42% were male. There were 813 patients (59%) with a pathological ACH test, 33% for CMD and 26% for epicardial vasospasm. A pathological test was more common in females (70% vs. 43%; p < 0.001). In a multivariable logistic regression model the sex difference was statistically significant with a female-male odds ratio for CMD and epicardial vasospasm of 4.2 (95% confidence interval: 3.1 to 5.5; p < 0.001) and 2.3 (95% confidence interval: 1.7 to 3.1; p < 0.001), respectively. Effort-related symptoms, but neither risk factors nor noninvasive stress tests, contributed to predicting a pathological test. Female patients were more sensitive to acetylcholine with vasomotor dysfunction occurring at lower ACH doses compared with male patients. CONCLUSIONS: Vasomotor dysfunction is frequent in patients with angina and unobstructed coronaries in a European population. Female patients have a higher prevalence of vasomotor dysfunction (especially CMD) compared with male patients. A pathological ACH test was observed at lower ACH doses in women compared with men.
引用
- Aziz A, Hansen HS, Sechtem U, et al. Sex-Related Differences in Vasomotor Function in Patients With Angina and Unobstructed Coronary Arteries. J Am Coll Cardiol. 2017. PMID: 29096805. doi:10.1016/j.jacc.2017.09.016
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。